MUMBAI (Reuters) - Dr Reddy's Laboratories Ltd , India's second-largest drugmaker, reported a quarterly profit below analysts' estimates due to a decline in sales in North America and Europe.
The company reported a profit of 3.09 billion rupees ($46.20 million), while analysts, on average, expected a profit of 3.4 billion rupees, according to Thomson Reuters I/B/E/S.
($1 = 66.8800 Indian rupees)
(Reporting by Zeba Siddiqui in Mumbai; Editing by Sherry Jacob-Phillips)
Disclaimer: No Business Standard Journalist was involved in creation of this content